tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Meridian Bioscience's activity chart (see below) currently has 42 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 83.7% with an average time for these price targets to be met of 248.67 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 08-Jul-2022. First documented stock forecast 04-May-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jul-2020
$34
$28.23 (489.25%)
$30
4 years 2 months 28 days ago
(08-Jul-2022)
6/9 (66.67%)
$1 (3.03%)
337
Buy Since 11-Aug-2020
$34
$28.23 (489.25%)
$34
5 years 7 months 13 days ago
(23-Feb-2021)
3/5 (60%)
$12.77 (60.15%)
96
Sell Since 01-May-2019
$9
$3.23 (55.98%)
$11
7 years 5 months 5 days ago
(01-May-2019)
8/8 (100%)
$-2.81 (-23.79%)
318
Hold Since 01-May-2019
$15
$9.23 (159.97%)
$15
7 years 5 months 5 days ago
(01-May-2019)
3/3 (100%)
$3.19 (27.01%)
267
Hold Since 03-Apr-2019
$12
$8.64 (257.14%)
$14
7 years 5 months 5 days ago
(01-May-2019)
2/2 (100%)
$0.19 (1.61%)
202
What is VIVO (Meridian Bioscience) average time for price targets to be met?
Which analyst most recently updated their price target on VIVO (Meridian Bioscience)?
Which analyst has the current lower performing score on VIVO (Meridian Bioscience) with a proven track record?
Which analyst has the most public recommendations on VIVO (Meridian Bioscience)?
Which analyst is the currently most bullish on VIVO (Meridian Bioscience)?
Which analyst is the currently most reserved on VIVO (Meridian Bioscience)?
